Eli Lilly and Nvidia Announce $1 Billion, Five-Year AI Co-Innovation Lab Partnership in Bay Area

Eli Lilly and Nvidia announced a five-year strategic partnership committing over $1 billion to establish a new AI co-innovation lab in the San Francisco Bay Area, set to open by late March 2026123

The lab will focus on accelerated drug discovery, clinical development, AI model training with real-world lab data, and applications in manufacturing using Nvidia's AI platforms like BioNeMo, Omniverse, Isaac, and Jetson13

This builds on their prior 'AI factory' supercomputer collaboration and was revealed at the 2026 J.P. Morgan Healthcare Conference on January 12, 2026123

Lilly provides drug R&D expertise and infrastructure, while Nvidia contributes AI capabilities, compute resources, and open biology models13

The partnership aims to create closed-loop discovery, physical AI, robotics, and address challenges like Eroom’s Law in drug development12

Sources:

1. https://www.fiercebiotech.com/biotech/lilly-nvidia-tag-partnership-new-ai-co-innovation-lab-1b-investment

2. http://business.times-online.com/times-online/article/marketminute-2026-1-12-the-ai-bio-convergence-lilly-and-nvidia-kick-off-jpm26-with-landmark-1-billion-alliance

3. https://www.bio-itworld.com/news/2026/01/12/nvidia-bets-big-on-ai-driven-drug-discovery--physical-ai--and-a--1-billion-eli-lilly-partnership